Received May 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 2 | Y014090 | IM / RA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | NT357 | IM / RA |
Patient received PEDIATRIC Recombivax instead of adult formulation. No adverse event/side effects noted or reported.
Unknown
Unknown
Unknown
None
none